Blogs » Business » Active Pharmaceutical Ingredients Market Growth and report 2028

Active Pharmaceutical Ingredients Market Growth and report 2028

  • IMARC Group’s latest research report, titled “Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the market. The active pharmaceutical ingredients (API) industry research report also includes competitor and regional analysis, and contemporary advancements in the market. The global active pharmaceutical ingredients (API) market size reached US$ 222.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028.

    Active Pharmaceutical Ingredients (API) Market Overview:

    Active pharmaceutical ingredients (API) are chemical compounds obtained from various sources, including plants, animals, and synthetic processes. They are synthetic active components of a finished pharmaceutical product (FPP) used to produce intended pharmacological outcomes. They are the substance in medications that are responsible for treating the illness or condition it is intended to treat. They are utilized in different medications, including prescription drugs, over-the-counter (OTC) medications, and dietary supplements.

    Get Free Sample Copy of Report at –

    Global Active Pharmaceutical Ingredients (API) Market Demand Analysis:

    The increasing prevalence of chronic diseases, cancer, arthritis, and respiratory disorders and the rising aging population, which is more prone to develop these medical conditions, represents one of the key factors driving the demand for APIs around the world. Moreover, the growing need for generic drugs on account of expanding healthcare costs is catalyzing the demand for APIs to improve the effectiveness of drugs. In addition, the increasing preference for personalized medicines and rising demand for biologic drugs that are made using living cells is favoring the market growth. Apart from this, regulatory authorities of numerous countries are implementing strict regulations to ensure the safety and quality of excipients used in the production of medicinal products. Furthermore, extensive research and development (R&D) activities in the pharmaceutical industry by key players to develop next-generation medicines and therapies are influencing the market positively.

    Top Active Pharmaceutical Ingredients Companies Worldwide:

    • Pfizer Inc.
    • Novartis International AG
    • Sanofi SA
    • Boehringer Ingelheim Group
    • Bristol-Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilly and Company
    • GlaxoSmithKline plc
    • Merck Co. Inc.
    • AbbVie Inc.

    Do you know more information, Contact to our analyst at–

    Key Market Segmentation:

    Breakup by Drug Type:

    • Innovative Active Pharmaceutical Ingredients (API)
    • Generic Active Pharmaceutical Ingredients (API)

    Breakup by Manufacturer:

    • Captive Manufacturers
    • Merchant API Manufacturers
      • Innovative Merchant API Manufacturers
      • Generic Merchant API Manufacturers

    Breakup by Synthesis:

    • Synthetic Active Pharmaceutical Ingredients (API)
    • Market Breakup by Type
    • Generic Synthetic APIs
    • Innovative Synthetic APIs
    • Biotech Active Pharmaceutical Ingredients (API)
    • Market Breakup by Type
    • Biosimilars
    • Innovative Biotech APIs
    • Market Breakup By ProductMonoclonal Antibodies
    • Blood Factors
    • Therapeutic Enzymes
    • Fusion Proteins
    • Cytokines
    •  Vaccines
    • Market Breakup By Expression System
    • Mammalian Expression Systems
    • Microbial Expression Systems
    • Yeast Expression Systems
    • Transgenic Animal Systems
    • Others

    Breakup by Therapeutic Application:

    • Oncology
    • Cardiovascular and Respiratory
    • Diabetes
    • Central Nervous System Disorders
    • Neurological Disorders
    • Others

    Breakup by Region:

    • North America (United States, Canada)
    • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
    • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
    • Latin America (Brazil, Mexico, Others)
    • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

    Who we are:

    IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

    IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

    Contact us:
    IMARC Group
    134 N 4th St. Brooklyn, NY 11249, USA
    Tel No:+91 120 433 0800
    Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800